Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Occlusion Based Dentifrice for Dentinal Hypersensitivity
NCT01831817Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2013
- Primary completion
- May 2013
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of calcium sodium phosphosilicate in Dentinal hypersensitivity (DH), sponsored by GSK. Started Jan 2013; status: completed.
02
Drugs
calcium sodium phosphosilicate
03
Conditions
Dentinal hypersensitivity (DH)
Beyond the preview
Go deeper on NCT01831817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01831817.